Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
The global Hereditary Angioedema market size is projected to reach US$ 2724.1 million by 2027, from US$ 1786.9 million in 2020, at a CAGR of 7.3% during 2022-2027.
The global Hereditary Angioedema market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Geographical Analysis:
Based on region, the global Hereditary Angioedema market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Hereditary Angioedema market are
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Hereditary Angioedema market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Hereditary Angioedema market.
• The market share of the global Hereditary Angioedema market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Hereditary Angioedema market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Hereditary Angioedema market.
The global Hereditary Angioedema market size is projected to reach US$ 2724.1 million by 2027, from US$ 1786.9 million in 2020, at a CAGR of 7.3% during 2022-2027.
The global Hereditary Angioedema market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Geographical Analysis:
Based on region, the global Hereditary Angioedema market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Hereditary Angioedema market are
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Hereditary Angioedema market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Hereditary Angioedema market.
• The market share of the global Hereditary Angioedema market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Hereditary Angioedema market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Hereditary Angioedema market.
1 Hereditary Angioedema Market Overview
1.1 Hereditary Angioedema Product Scope
1.2 Hereditary Angioedema Segment by Type
1.2.1 Global Hereditary Angioedema Sales by Type (2016 & 2021 & 2027)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Segment by Application
1.3.1 Global Hereditary Angioedema Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Hereditary Angioedema Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hereditary Angioedema Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hereditary Angioedema Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hereditary Angioedema Price Trends (2016-2027)
2 Hereditary Angioedema Estimates and Forecasts by Region
2.1 Global Hereditary Angioedema Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hereditary Angioedema Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hereditary Angioedema Sales Market Share by Region (2016-2021)
2.2.2 Global Hereditary Angioedema Revenue Market Share by Region (2016-2021)
2.3 Global Hereditary Angioedema Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hereditary Angioedema Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hereditary Angioedema Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.2 Europe Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.3 China Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.4 Japan Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.6 India Hereditary Angioedema Estimates and Projections (2016-2027)
3 Global Hereditary Angioedema Competition Landscape by Players
3.1 Global Top Hereditary Angioedema Players by Sales (2016-2021)
3.2 Global Top Hereditary Angioedema Players by Revenue (2016-2021)
3.3 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2020)
3.4 Global Hereditary Angioedema Average Price by Company (2016-2021)
3.5 Manufacturers Hereditary Angioedema Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hereditary Angioedema Market Size by Type
4.1 Global Hereditary Angioedema Historic Market Review by Type (2016-2021)
4.1.1 Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
4.1.2 Global Hereditary Angioedema Revenue Market Share by Type (2016-2021)
4.1.3 Global Hereditary Angioedema Price by Type (2016-2021)
4.2 Global Hereditary Angioedema Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hereditary Angioedema Sales Forecast by Type (2022-2027)
4.2.2 Global Hereditary Angioedema Revenue Forecast by Type (2022-2027)
4.2.3 Global Hereditary Angioedema Price Forecast by Type (2022-2027)
5 Global Hereditary Angioedema Market Size by Application
5.1 Global Hereditary Angioedema Historic Market Review by Application (2016-2021)
5.1.1 Global Hereditary Angioedema Sales Market Share by Application (2016-2021)
5.1.2 Global Hereditary Angioedema Revenue Market Share by Application (2016-2021)
5.1.3 Global Hereditary Angioedema Price by Application (2016-2021)
5.2 Global Hereditary Angioedema Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hereditary Angioedema Sales Forecast by Application (2022-2027)
5.2.2 Global Hereditary Angioedema Revenue Forecast by Application (2022-2027)
5.2.3 Global Hereditary Angioedema Price Forecast by Application (2022-2027)
6 North America Hereditary Angioedema Market Facts & Figures
6.1 North America Hereditary Angioedema Sales by Company
6.1.1 North America Hereditary Angioedema Sales by Company (2016-2021)
6.1.2 North America Hereditary Angioedema Revenue by Company (2016-2021)
6.2 North America Hereditary Angioedema Sales Breakdown by Type
6.2.1 North America Hereditary Angioedema Sales Breakdown by Type (2016-2021)
6.2.2 North America Hereditary Angioedema Sales Breakdown by Type (2022-2027)
6.3 North America Hereditary Angioedema Sales Breakdown by Application
6.3.1 North America Hereditary Angioedema Sales Breakdown by Application (2016-2021)
6.3.2 North America Hereditary Angioedema Sales Breakdown by Application (2022-2027)
7 Europe Hereditary Angioedema Market Facts & Figures
7.1 Europe Hereditary Angioedema Sales by Company
7.1.1 Europe Hereditary Angioedema Sales by Company (2016-2021)
7.1.2 Europe Hereditary Angioedema Revenue by Company (2016-2021)
7.2 Europe Hereditary Angioedema Sales Breakdown by Type
7.2.1 Europe Hereditary Angioedema Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hereditary Angioedema Sales Breakdown by Type (2022-2027)
7.3 Europe Hereditary Angioedema Sales Breakdown by Application
7.3.1 Europe 118 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 118 Sales Breakdown by Application (2022-2027)
8 China Hereditary Angioedema Market Facts & Figures
8.1 China Hereditary Angioedema Sales by Company
8.1.1 China Hereditary Angioedema Sales by Company (2016-2021)
8.1.2 China Hereditary Angioedema Revenue by Company (2016-2021)
8.2 China Hereditary Angioedema Sales Breakdown by Type
8.2.1 China Hereditary Angioedema Sales Breakdown by Type (2016-2021)
8.2.2 China Hereditary Angioedema Sales Breakdown by Type (2022-2027)
8.3 China Hereditary Angioedema Sales Breakdown by Application
8.3.1 China 145 Sales Breakdown by Application (2016-2021)
8.3.2 China 145 Sales Breakdown by Application (2022-2027)
9 Japan Hereditary Angioedema Market Facts & Figures
9.1 Japan Hereditary Angioedema Sales by Company
9.1.1 Japan Hereditary Angioedema Sales by Company (2016-2021)
9.1.2 Japan Hereditary Angioedema Revenue by Company (2016-2021)
9.2 Japan Hereditary Angioedema Sales Breakdown by Type
9.2.1 Japan Hereditary Angioedema Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hereditary Angioedema Sales Breakdown by Type (2022-2027)
9.3 Japan Hereditary Angioedema Sales Breakdown by Application
9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hereditary Angioedema Market Facts & Figures
10.1 Southeast Asia Hereditary Angioedema Sales by Company
10.1.1 Southeast Asia Hereditary Angioedema Sales by Company (2016-2021)
10.1.2 Southeast Asia Hereditary Angioedema Revenue by Company (2016-2021)
10.2 Southeast Asia Hereditary Angioedema Sales Breakdown by Type
10.2.1 Southeast Asia Hereditary Angioedema Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hereditary Angioedema Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hereditary Angioedema Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Hereditary Angioedema Market Facts & Figures
11.1 India Hereditary Angioedema Sales by Company
11.1.1 India Hereditary Angioedema Sales by Company (2016-2021)
11.1.2 India Hereditary Angioedema Revenue by Company (2016-2021)
11.2 India Hereditary Angioedema Sales Breakdown by Type
11.2.1 India Hereditary Angioedema Sales Breakdown by Type (2016-2021)
11.2.2 India Hereditary Angioedema Sales Breakdown by Type (2022-2027)
11.3 India Hereditary Angioedema Sales Breakdown by Application
11.3.1 India Hereditary Angioedema Sales Breakdown by Application (2016-2021)
11.3.2 India Hereditary Angioedema Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hereditary Angioedema Business
12.1 Pharming Group NV
12.1.1 Pharming Group NV Corporation Information
12.1.2 Pharming Group NV Business Overview
12.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pharming Group NV Hereditary Angioedema Products Offered
12.1.5 Pharming Group NV Recent Development
12.2 Takeda
12.2.1 Takeda Corporation Information
12.2.2 Takeda Business Overview
12.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Hereditary Angioedema Products Offered
12.2.5 Takeda Recent Development
12.3 CSL Limited
12.3.1 CSL Limited Corporation Information
12.3.2 CSL Limited Business Overview
12.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Limited Hereditary Angioedema Products Offered
12.3.5 CSL Limited Recent Development
12.4 iBio Inc.
12.4.1 iBio Inc. Corporation Information
12.4.2 iBio Inc. Business Overview
12.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.4.4 iBio Inc. Hereditary Angioedema Products Offered
12.4.5 iBio Inc. Recent Development
12.5 BioCryst Pharmaceuticals, Inc.
12.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
12.5.2 BioCryst Pharmaceuticals, Inc. Business Overview
12.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
12.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
12.6 Ionis Pharmaceuticals, Inc.
12.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
12.6.2 Ionis Pharmaceuticals, Inc. Business Overview
12.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
12.6.5 Ionis Pharmaceuticals, Inc. Recent Development
...
13 Hereditary Angioedema Manufacturing Cost Analysis
13.1 Hereditary Angioedema Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereditary Angioedema
13.4 Hereditary Angioedema Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereditary Angioedema Distributors List
14.3 Hereditary Angioedema Customers
15 Market Dynamics
15.1 Hereditary Angioedema Market Trends
15.2 Hereditary Angioedema Drivers
15.3 Hereditary Angioedema Market Challenges
15.4 Hereditary Angioedema Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
1.1 Hereditary Angioedema Product Scope
1.2 Hereditary Angioedema Segment by Type
1.2.1 Global Hereditary Angioedema Sales by Type (2016 & 2021 & 2027)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Segment by Application
1.3.1 Global Hereditary Angioedema Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Hereditary Angioedema Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hereditary Angioedema Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hereditary Angioedema Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hereditary Angioedema Price Trends (2016-2027)
2 Hereditary Angioedema Estimates and Forecasts by Region
2.1 Global Hereditary Angioedema Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hereditary Angioedema Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hereditary Angioedema Sales Market Share by Region (2016-2021)
2.2.2 Global Hereditary Angioedema Revenue Market Share by Region (2016-2021)
2.3 Global Hereditary Angioedema Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hereditary Angioedema Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hereditary Angioedema Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.2 Europe Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.3 China Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.4 Japan Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hereditary Angioedema Estimates and Projections (2016-2027)
2.4.6 India Hereditary Angioedema Estimates and Projections (2016-2027)
3 Global Hereditary Angioedema Competition Landscape by Players
3.1 Global Top Hereditary Angioedema Players by Sales (2016-2021)
3.2 Global Top Hereditary Angioedema Players by Revenue (2016-2021)
3.3 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2020)
3.4 Global Hereditary Angioedema Average Price by Company (2016-2021)
3.5 Manufacturers Hereditary Angioedema Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hereditary Angioedema Market Size by Type
4.1 Global Hereditary Angioedema Historic Market Review by Type (2016-2021)
4.1.1 Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
4.1.2 Global Hereditary Angioedema Revenue Market Share by Type (2016-2021)
4.1.3 Global Hereditary Angioedema Price by Type (2016-2021)
4.2 Global Hereditary Angioedema Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hereditary Angioedema Sales Forecast by Type (2022-2027)
4.2.2 Global Hereditary Angioedema Revenue Forecast by Type (2022-2027)
4.2.3 Global Hereditary Angioedema Price Forecast by Type (2022-2027)
5 Global Hereditary Angioedema Market Size by Application
5.1 Global Hereditary Angioedema Historic Market Review by Application (2016-2021)
5.1.1 Global Hereditary Angioedema Sales Market Share by Application (2016-2021)
5.1.2 Global Hereditary Angioedema Revenue Market Share by Application (2016-2021)
5.1.3 Global Hereditary Angioedema Price by Application (2016-2021)
5.2 Global Hereditary Angioedema Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hereditary Angioedema Sales Forecast by Application (2022-2027)
5.2.2 Global Hereditary Angioedema Revenue Forecast by Application (2022-2027)
5.2.3 Global Hereditary Angioedema Price Forecast by Application (2022-2027)
6 North America Hereditary Angioedema Market Facts & Figures
6.1 North America Hereditary Angioedema Sales by Company
6.1.1 North America Hereditary Angioedema Sales by Company (2016-2021)
6.1.2 North America Hereditary Angioedema Revenue by Company (2016-2021)
6.2 North America Hereditary Angioedema Sales Breakdown by Type
6.2.1 North America Hereditary Angioedema Sales Breakdown by Type (2016-2021)
6.2.2 North America Hereditary Angioedema Sales Breakdown by Type (2022-2027)
6.3 North America Hereditary Angioedema Sales Breakdown by Application
6.3.1 North America Hereditary Angioedema Sales Breakdown by Application (2016-2021)
6.3.2 North America Hereditary Angioedema Sales Breakdown by Application (2022-2027)
7 Europe Hereditary Angioedema Market Facts & Figures
7.1 Europe Hereditary Angioedema Sales by Company
7.1.1 Europe Hereditary Angioedema Sales by Company (2016-2021)
7.1.2 Europe Hereditary Angioedema Revenue by Company (2016-2021)
7.2 Europe Hereditary Angioedema Sales Breakdown by Type
7.2.1 Europe Hereditary Angioedema Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hereditary Angioedema Sales Breakdown by Type (2022-2027)
7.3 Europe Hereditary Angioedema Sales Breakdown by Application
7.3.1 Europe 118 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 118 Sales Breakdown by Application (2022-2027)
8 China Hereditary Angioedema Market Facts & Figures
8.1 China Hereditary Angioedema Sales by Company
8.1.1 China Hereditary Angioedema Sales by Company (2016-2021)
8.1.2 China Hereditary Angioedema Revenue by Company (2016-2021)
8.2 China Hereditary Angioedema Sales Breakdown by Type
8.2.1 China Hereditary Angioedema Sales Breakdown by Type (2016-2021)
8.2.2 China Hereditary Angioedema Sales Breakdown by Type (2022-2027)
8.3 China Hereditary Angioedema Sales Breakdown by Application
8.3.1 China 145 Sales Breakdown by Application (2016-2021)
8.3.2 China 145 Sales Breakdown by Application (2022-2027)
9 Japan Hereditary Angioedema Market Facts & Figures
9.1 Japan Hereditary Angioedema Sales by Company
9.1.1 Japan Hereditary Angioedema Sales by Company (2016-2021)
9.1.2 Japan Hereditary Angioedema Revenue by Company (2016-2021)
9.2 Japan Hereditary Angioedema Sales Breakdown by Type
9.2.1 Japan Hereditary Angioedema Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hereditary Angioedema Sales Breakdown by Type (2022-2027)
9.3 Japan Hereditary Angioedema Sales Breakdown by Application
9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hereditary Angioedema Market Facts & Figures
10.1 Southeast Asia Hereditary Angioedema Sales by Company
10.1.1 Southeast Asia Hereditary Angioedema Sales by Company (2016-2021)
10.1.2 Southeast Asia Hereditary Angioedema Revenue by Company (2016-2021)
10.2 Southeast Asia Hereditary Angioedema Sales Breakdown by Type
10.2.1 Southeast Asia Hereditary Angioedema Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hereditary Angioedema Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hereditary Angioedema Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Hereditary Angioedema Market Facts & Figures
11.1 India Hereditary Angioedema Sales by Company
11.1.1 India Hereditary Angioedema Sales by Company (2016-2021)
11.1.2 India Hereditary Angioedema Revenue by Company (2016-2021)
11.2 India Hereditary Angioedema Sales Breakdown by Type
11.2.1 India Hereditary Angioedema Sales Breakdown by Type (2016-2021)
11.2.2 India Hereditary Angioedema Sales Breakdown by Type (2022-2027)
11.3 India Hereditary Angioedema Sales Breakdown by Application
11.3.1 India Hereditary Angioedema Sales Breakdown by Application (2016-2021)
11.3.2 India Hereditary Angioedema Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hereditary Angioedema Business
12.1 Pharming Group NV
12.1.1 Pharming Group NV Corporation Information
12.1.2 Pharming Group NV Business Overview
12.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pharming Group NV Hereditary Angioedema Products Offered
12.1.5 Pharming Group NV Recent Development
12.2 Takeda
12.2.1 Takeda Corporation Information
12.2.2 Takeda Business Overview
12.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Hereditary Angioedema Products Offered
12.2.5 Takeda Recent Development
12.3 CSL Limited
12.3.1 CSL Limited Corporation Information
12.3.2 CSL Limited Business Overview
12.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Limited Hereditary Angioedema Products Offered
12.3.5 CSL Limited Recent Development
12.4 iBio Inc.
12.4.1 iBio Inc. Corporation Information
12.4.2 iBio Inc. Business Overview
12.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.4.4 iBio Inc. Hereditary Angioedema Products Offered
12.4.5 iBio Inc. Recent Development
12.5 BioCryst Pharmaceuticals, Inc.
12.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
12.5.2 BioCryst Pharmaceuticals, Inc. Business Overview
12.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
12.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
12.6 Ionis Pharmaceuticals, Inc.
12.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
12.6.2 Ionis Pharmaceuticals, Inc. Business Overview
12.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
12.6.5 Ionis Pharmaceuticals, Inc. Recent Development
...
13 Hereditary Angioedema Manufacturing Cost Analysis
13.1 Hereditary Angioedema Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereditary Angioedema
13.4 Hereditary Angioedema Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereditary Angioedema Distributors List
14.3 Hereditary Angioedema Customers
15 Market Dynamics
15.1 Hereditary Angioedema Market Trends
15.2 Hereditary Angioedema Drivers
15.3 Hereditary Angioedema Market Challenges
15.4 Hereditary Angioedema Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
